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Abstract 
Background 
Gentiana floribunda was investigated for the possible hypotensive and vasodilator activities 
in an attempt to rationalize its traditional use in hypertension. 
Methods 
The crude extract of Gentiana floribunda (Gf.Cr) was studied in anaesthetized rats and 
isolated thoracic aorta tissues. 
Results 
Gf.Cr which tested positive for presence of flavonoids, saponins, sterols, tannins and terpenes 
caused dose-dependent (3.0-100 mg/kg) fall in arterial blood pressure (BP) of rats under 
anaesthesia. In rat aortic ring preparations denuded of endothelium, Gf.Cr at concentration 
range of 1.0-10 mg/mL relaxed high K
+
 (80 mM) and phenylephrine (PE, 1 μM)-induced 
contractions and shifted Ca
++
 dose–response curves to right, similar to that caused by 
verapamil. It also suppressed PE (1 μM) control peak responses at 0.3-1.0 mg/mL, obtained 
in Ca
++
-free medium, as exhibited by verapamil. Pre-treatment of tissues with Gf.Cr produced 
rightward non-parallel shift of PE-curves with decline of maximum contractile response. The 
vasodilator effect of Gf.Cr was endothelial-independent, as it was not blocked by Nω-nitro-L-
arginine methyl ester hydrochloride, atropine and indomethacin in endothelium-intact aortic 
tissues. 
Conclusions 
These data indicate that BP-lowering action of Gentiana floribunda occurred via Ca
++
 
antagonism (inhibition of Ca
++
 ingress and release from intracellular stores), which provides 
pharmacological basis to justify its effectiveness in hypertension. 
Background 
Hypertension is one of the most common and rapidly spreading cardiovascular diseases, 
which is a major cause of morbidity and mortality in mankind and an important risk factor for 
the development of other cardiovascular diseases [1]. The pathophysiologic basis for over 90 
percent cases of disease remains unexplained, and therefore, the condition is called primary 
or essential hypertension. The heritability of essential hypertension is estimated to be about 
30%. The remaining 5–10 percent may be due to a number of known causes, including renal 
artery stenosis, aortic coarctation, cushing’s syndrome and pheochromocytoma, called 
secondary hypertension [2]. Hypertension is a serious affliction that is often asymptomatic. 
Over time, it leads to a variety of health problems including premature sickness, stroke, 
congestive heart failure, myocardial infarction, peripheral vascular disease, retinopathy, 
dementia, renal dysfunction, cerebro-vascular damage, disability and death in the adult 
population [3]. The hypertension-related morbidity and mortality are directly related to the 
level of blood pressure (BP). The incidence of morbidity and mortality significantly 
decreases when hypertension is diagnosed early and is properly treated, whereas untreated 
hypertension is known as the ‘silent killer’. The risk of developing a cardiovascular 
complication is higher when the individual combines hypertension with other risk factors, 
such as hypercholesterolemia, diabetes and a family history of cardiovascular diseases [4]. 
The conventional therapy for the hypertension is not always safe, efficacious and is beyond 
the access and/or affordability of large proportion of world population, who looks for 
alternative therapeutic measures [5]. Phytotherapy is the most popular alternative remedy and 
a number of traditional systems of medicine are heavily based on the use of herbs as 
medicine. At the same time, there is a global revival of interest in the use of botanicals and 
physicians of the modern medicine are now beginning to accept the traditional remedies 
following scientificant validation [6]. Previously, few species of the genus “Gentiana” were 
evaluated for cardiovascular inhibitory activities. For example, Gentiana olivieri and 
Gentiana kokiana are reported to exhibit hypotensive and vasodilatory actions respectively 
[7,8]. Gentiana floribunda Don. (Gentianaceae) is an erect annual or perennial herb, native of 
Himalaya region. The plant is used in a traditional medical system for the treatment of variety 
of health ailments, such as hypertension, gastrointestinal motility, congestive respiratory, 
hepato-biliary and neurological disorders [9,10]. Despite the fact that Gentiana floribunda 
has been used medicinally, it has not been widely studied scientifically. In view of our project 
aimed at the ethnopharmacological evaluation of medicinal plants for cardiovascular effects, 
the present research was carried out to explore the possible mechanism of action involved in 
the hypotensive potential of Gentiana floribunda. We report here that it exhibits BP-lowering 
and endothelium-independent vasodilatory effects, mediated through dual inhibition of Ca
++
 
influx across membranous voltage-sensitive and receptor-operated Ca
++
 channels as well as 
its release from intracellular sarcoplasmic reticulum stores. This study provides a sound 
mechanistic background for the medicinal application of Gentiana floribunda in 
hypertension. 
Methods 
Plant material and extraction 
Gentiana floribunda whole plant material was collected from Kurram valley, Pakistan in 
2009 and identified with help of botanical authority at Kohat University of Science and 
Technology, Kohat, Pakistan and voucher specimen was deposited at Herbarium of the same 
University. The plant material was cleaned, shade dried and coarsely ground. The powdered 
material (1.5 kg) was soaked in 70% aqueous-methanol solution in a large container for 3 
days with occasional shaking. It was filtered through a muslin cloth and then through filter 
paper [11]. This procedure was repeated twice more and the combined filtrate was evaporated 
on a rotary evaporator, under reduced pressure to a thick semi-solid mass of dark brown color 
i.e. the crude extract of Gentiana floribunda (Gf.Cr, 250 g), yielding 16.7%. Gf.Cr was 
solubilized both in saline and distilled water. 
Chemicals 
The following reference chemicals were obtained from the sources specified: acetylcholine 
chloride (ACh), atropine, indomethacin, Nω-nitro-L-arginine methyl ester hydrochloride (L-
NAME), norepinephrine hydrochloride (NE), phentolamine hydrochloride, phenylephrine 
hydrochloride (PE), urethane and verapamil hydrochloride (Sigma Chemical Company, St. 
Louis, MO, USA). The following chemicals were used to make physiological salt solutions: 
potassium chloride (Sigma Chemical Company, St. Louis, MO, USA), calcium chloride, 
glucose, magnesium sulphate, potassium dihydrogen phosphate, sodium bicarbonate, sodium 
chloride (Merck, Darmstadt, Germany) and ethylenediaminetetra-acetic acid (EDTA) from 
BDH Laboratory Supplies, Poole, England. The chemicals used in phytochemical analysis 
include: acetic anhydride, aluminum chloride, ammonium hydroxide, ferric chloride (Sigma 
Chemical Co, St Louis, MO, USA), benzene, chloroform, hydrochloric acid and petroleum 
ether (BDH Laboratory supplies, Poole, England). All chemicals used were of the highest 
analytical grade available. 
Phytochemical screening 
Preliminary phytochemical screening of the extract was carried out for the presence of 
anthraquinones, coumarins, flavonoids, saponins, sterols, tannins and terpenes in accordance 
to the reported procedures [12]. Presence of saponins was detected based on the appearance 
of froth upon vigorous shaking of diluted samples. The observation of yellow florescence 
under ultraviolet light on examination of filter paper previously exposed to the vapors from 
boiling plant material indicated the presence of coumarins. For the detection of sterols and 
terpenes, plant material was treated with petroleum ether and subsequently extracted with 
CHCl3. The gradual appearance of green to pink (for sterols) and pink to purple color (for 
terpenes) was then noted after treatment of CHCl3 layer with acetic anhydride and 
concentrated H2SO4 in succession. Plant material was detected as positive for flavonoids 
when it gave yellow color with AlCl3 reagent and for tannins, when green or black color was 
produced with aqueous FeCl3. Lastly, for detecting anthraquinones, the extract was dissolved 
in 1% HCl, then in benzene and later if extract showed pink, violet or red color with NH4OH, 
that indicate the presence of anthraquinones. 
Animals 
Male Sprague–Dawley rats (240–260 g) of local breed were housed at animal house of the 
Department of Pharmacology, University of Malaya, under controlled environment (23-25 
°C). Animals were given tap water ad libitum and standard diet. Experiments performed 
complied with rulings of the Institute of Laboratory Animal Resources, Commission on Life 
Sciences, National Research Council [13], approved by University of Malaya Animal 
Experimentation Ethics Committee. 
Measurement of blood pressure 
These experiments were performed according to method described previously [14]. Rats were 
anaesthetized with urethane (1.2-1.5 g/kg, i.p.). Animal was fixed in supine position on a 
dissecting table. A small mid-tracheal incision (approx. 1 cm) was made to expose trachea, 
right jugular vein and left carotid artery. The trachea was cannulated with a polyethylene 
tubing Pe-20 to maintain the spontaneous respiration and cleaned from time to time. The right 
jugular vein was cannulated with polyethylene tubing Pe-50 to facilitate the intravenous 
administration of drugs. The left carotid artery was cannulated with similar tubing filled with 
heparinized saline 60 IU/mL and connected to a pressure transducer (MLT 0380/D Reusable 
BP- Transducer) coupled to ML 224 Quad Bridge Amplifier and PowerLab ML 4/30 data 
acquisition system (AD Instruments, Sydney, Australia) for BP recording. The exposed 
surface for cannulation was covered with a piece of gauze moistened in warm saline. Rats 
were injected with heparinized 0.1 mL saline (0.9% NaCl) to prevent blood clotting. Body 
temperature of the animal was maintained by using overhead lamp. Following 20 min period 
of equilibrium, rats were injected intravenously with test substance. Arterial BP was allowed 
to return to resting level between injections. Changes in BP were recognized as difference 
between the steady state values before and the peak readings after injection. Mean arterial 
blood pressure (MABP) was calculated as the diastolic BP plus one-third of the pulse width 
(systolic BP - diastolic BP). The ACh (1 μg/kg) and NE (1 μg/kg) control responses were 
obtained before the administration of any test material. 
Isolated rat aorta preparations 
Rats were sacrificed by cervical dislocation. After abodominal opening, the thoracic aorta 
was dissected out, cleaned of fat and adipose tissues and cut into 3–5 mm long rings and 
individually mounted in 5 mL tissue bath containing Kreb’s solution composed of mM): 
NaCl 118.2, NaHCO3 25.0, CaCl2 2.5, KCl 4.7, KH2PO4 1.3, MgSO4 1.2 and glucose 11.7 
(pH 7.4). The bath solution was maintained at 37 °C and continuously aerated with carbogen 
(95% O2 in 5% CO2). A resting tension of 1 g was applied to each tissue and an equilibrium 
period of 30 min was allowed before any experimentation. The tissues were then stabilized 
with repeated exposure (usually 3-times) to high KCl solution [15]. In experiments using 
endothelium-denuded tissues, endothelium lining of the aortic rings was removed 
mechanically by gentle rubbing with blunted forceps. Denudation of endothelium was 
confirmed by the absence of relaxation to ACh, 0.1-0.3 μM [16]. The test drug was tested for 
its ability to relax the contractions, induced with high K
+
 (80 mM) and PE, 1 μM. The ability 
of extract to relax K
+
 (80 mM)-induced contractions would indicate L-type voltage-operated 
calcium channel blocking (CCB) mode of vasodilation, while inhibition of the PE-induced 
contractions, would signify blockade of the Ca
++
 influx through receptor-operated calcium 
channels [17,18]. To confirm CCB activity, concentration-response curves (CRCS) of Ca
++
 
were constructed [19]. For this purpose tissue was stabilized in normal Kreb’s solution and 
then placed in Ca
++
-free Kreb’s solution, containing EDTA (0.1 mM) for 30 min to remove 
calcium from the tissues. This solution was further replaced with K
+
-rich and Ca
++
-free 
Kreb’s solution, having the following composition (mM): KCl 50, NaCl 50.58, MgSO4 3.10., 
NaHCO3 23.8, KH2PO4 1.26, glucose 11.1 and EDTA 0.1. Following an incubation period of 
1 hr, control CRCS of Ca
++
 were obtained. When the control CRCS of Ca
++
 were found super-
imposable (usually after two cycles), the tissue was pre-treated with test drug for 50–60 min 
for the possible CCB effect. The Ca
++
-CRCS were reconstructed in presence of different 
concentrations of the test material. In order to determine if the extract was inhibiting Ca
++
 
release from intracellular stores, the effect of increasing concentrations of extract was 
observed on PE (1 μM) peaks obtained in the Ca++-free environment (Ca++ omitted and 
EDTA (0.1 mM) added) to ensure total elimination of extracellular Ca
++
 without harmful 
effects on Ca
++
 inside the cell [20]. In Ca
++
-free medium, PE acts through stimulation of α1-
adrenergic receptors. Consequent conversion of phosphatidylinositol to inositol triphosphate 
(IP3), which in turn releases Ca
++
 from the intracellular stores, brings about the contraction 
[21]. To assess the presence of any competitive adrenergic antagonism, cumulative curves to 
PE were constructed using increasing concentration of agonist. When 3-fold increase in 
concentration produced no further increment in response, the tissue was washed to re-
establish the base-line tension (within 30–35 min). The PE-curves were then re-determined in 
the presence of test material. To study whether or not the vasodilator effect of test substances 
is endothelium-dependent, endothelium-intact aortic rings were preincubated with L-NAME 
(0.1 mM), atropine (1 μM) and indomethacin (1 μM) for 60 min prior to PE (1 μM)-induced 
contractions [22]. The endothelial integrity of aortic ring was indicated by administration of 
ACh (0.1 μM) on PE-induced contraction, resulting in vasorelaxation [23]. Changes in 
tension were recorded and analyzed isometrically, using force transducers of Multi Wire 
Myograph system-Model 610 M-version 2.2 (DMT A/S, Skejbyparken152, 8200 Aarhus N., 
Denmark) coupled to PowerLab ML 8/30 data acquisition system (AD Instruments, Sydney, 
Australia). 
Acute toxicity test 
Mice were divided in groups of five mice each. The test was performed using increasing 
doses of the plant extract, given orally in 10 mL/kg volume to different groups serving as test 
groups. Another group of mice was administered saline (10 mL/kg, p.o.) as negative control. 
The mice were allowed food ad libitum and kept under regular observation for lethality 
recorded after 24 hrs [24]. 
Statistical analysis 
All the data is expressed as mean ± SEM and the median effective concentrations (EC50) 
values are given as geometric mean with 95% confidence intervals (CI). CRCs were analyzed 
by nonlinear regression (Sigmoidal dose–response curve variable slop). The statistical 
parameter applied was one way analysis of variance (ANOVA). Difference of p < 0.05 was 
considered statistically significant. All the graphs, calculation and statistical analyses were 
performed using GraphPad Prism software version 4.00 for Windows (GraphPad Software, 
San Diego California USA). 
Results 
Phytochemical analysis 
Gf.Cr was found to contain flavonoids, saponins, sterols, tannins and terpenes, while tested 
negative for the rest of classes. 
Effect on blood pressure 
Gf.Cr at the doses of 3, 10, 30 and 100 mg/kg caused a respective fall of 5.5 ± 1.0, 11.7 ± 2.0, 
19.5 ± 2.2 and 29.5 ± 2.1% (n = 4) in the MABP (p < 0.01 and p < 0.001 vs. saline) of 
anaesthetized rats. Figure 1A shows tracing from a typical experiment, whereas combined 
data from different experiments are presented in Figure 1B. 
Figure 1 Upper panel (A) shows a typical tracing of Gentiana floribunda (Gf.Cr) blood 
pressure (BP) lowering effect and the lower panel (B) shows a bar chart representing 
effect of saline (0.1 mL) and Gf.Cr on mean arterial blood pressure (MABP) in 
anesthetized rats. The dose was administered after the response to the preceding one had 
returned to normal. Values shown represent mean ± SEM, n = 4. **p < 0.01 and ***p < 0.001 vs. 
saline treatment 
Effect on high K+ and PE-induced contractions 
When tested on the resting base-line of endothelium-denuded aortic preparations, the extract 
was devoid of vasoconstrictor effect up to 10 mg/mL. When tested on K
+
 (80 mM) and PE (1 
μM)-induced contractions, Gf.Cr produced non-specific (p > 0.05) vasodilator effect with 
respective EC50 values of 2.7 (2.2-3.1, n = 4) and 2.4 mg/mL (2.1-2.7, n = 4) as shown in 
Figure 2A. Verapamil was also free of any vasoconstrictor effect and inhibited the K
+
 (80 
mM) and PE (1 μM)-induced vascular contractions (p > 0.05) with EC50 values of 1.6 (0.76-
3.1, n = 4) and 1.9 μM (0.84-4.9, n = 4) respectively (Figure 2B). 
Figure 2 Concentration-dependent relaxant effects of (A) crude extract of Gentiana 
floribunda (Gf.Cr) and (B) verapamil on high K
+
 and phenylephrine (PE)-induced 
contractions in isolated rat aortic ring preparations. Values shown are mean ± SEM, n = 4. 
The K
+
 and PE curves in each graph are non-significantly different (p > 0.05) 
Effect on Ca++-curves 
Gf.Cr in a concentrations-dependent manner (0.3-1.0 mg/mL, n = 4) shifted the Ca++-CRCs 
(p < 0.05, p < 0.01 and p < 0.001) to the right with suppression of the maximum contraction 
(Figure 3A). This rightward shift of Ca
++
-curves was similar to the one obtained under the 
influence of verapamil (0.03-0.1 μM, n = 4, p < 0.01 and p < 0.001) as shown in Figure 3B. 
Figure 3 Concentration-response curves of Ca
++
 in the absence and presence of different 
concentrations of (A) crude extract of Gentiana floribunda (Gf.Cr) and (B) verapamil in 
isolated rat aortic ring preparations. Values shown are mean ± SEM, n = 4. *p < 0.05, 
**
p < 0.01 and ***p < 0.001 compared to respective concentrations values in the Ca++ control 
curves 
Effect on PE-peak responses 
In Ca
++
-free medium, Gf.Cr at the concentrations of 0.3 and 1.0 mg/mL caused 54.5 ± 5.1 
and 91.3 ± 3.2% (n = 4) suppression (p < 0.001) of PE (1 μM) peak responses respectively 
(Figure 4A). This response was similar to verapamil, which inhibited the PE-peaks at 0.3 and 
1.0 μM by 33.25 ± 3.5 and 85.0 ± 2.5% (n = 4) respectively (p < 0.01 and p < 0.001) as shown 
in Figure 4B. 
Figure 4 Inhibitory effect of increasing concentrations of (A) crude extract of Gentiana 
floribunda (Gf.Cr) and (B) verapamil on control phenylephrine (PE) peak responses in 
Ca
++
 free medium in isolated rat aortic ring preparations. Values shown are mean ± SEM, 
n = 4. **p < 0.01 and ***p < 0.001 compared to PE control peaks 
Effect on PE-curves 
PE cumulative CRCs were constructed in the absence and presence of test drugs. Gf.Cr at 3 
mg/mL shifted the PE-curves to the right in non-parallel fashion with suppression (p < 0.001) 
of the agonist maximal response (Figure 5A). This response was similar to that caused by 
verapamil at 3 μM (p < 0.001) as shown in Figure 5B, while phentolamine (1 μM) caused 
rightward (p < 0.05 and p < 0.001) parallel shift without suppressing maximum contractile 
effect (Figure 5C). 
Figure 5 Concentration-response curves of phenylephrine (PE) in the absence and 
presence of (A) crude extract of Gentiana floribunda (Gf.Cr), (B) verapamil and (C) 
phentolamine in isolated rat aortic ring preparations. Values shown are mean ± SEM, 
n = 4. *p < 0.05, **p < 0.01 and ***p < 0.001 compared to respective concentrations values in 
the PE control curves 
Effect on endothelium-intact tissues 
In endothelium-intact rat aortic rings, Gf.Cr relaxed the PE (1 μM)-induced contractions 
(p > 0.05) in absence of any intervention and in presence of L-NAME (0.1 mM), atropine (1 
μM) and indomethacin (1 μM) with respective EC50 values of 2.8 (2.5-3.3, n = 4), 2.9 (2.7-
3.1, n = 4), 3.0 (2.8-3.2, n = 4) and 2.6 mg/mL (2.1-2.9, n = 4) as shown in Figure 6. 
Figure 6 Inhibitory effect of the crude extract of Gentiana floribunda (Gf.Cr) on PE (1 
μM)-induced contractions in the absence and presence of Nω-nitro-L-arginine methyl 
ester hydrochloride (L-NAME, 0.1 mM), atropine (1 μM) and indomethacin (1 μM) in 
endothelium-intact aortic preparations from isolated rat aorta. Values shown are 
mean ± SEM, n = 4. The curves are non-significantly different (p > 0.05) 
Preliminary toxicity study 
The two different groups of mice were given Gf.Cr in the graded doses of 1 and 3 g/kg 
respectively and animals were observed for mortality after 24 hrs of drug administration. The 
extract did not cause any mortality up to the dose of 3 g/kg. 
Discussion 
The intravenous administration of hydro-methanolic extract of Gentiana floribunda caused a 
dose-dependent fall in the arterial BP of rats, which is in line with its medicinal use in 
hypertension. It is customary to use isolated vascular tissue preparations to investigate the 
possible mode of hypotensive action, as response interference from intact reflex is obliterated 
[25]. To see effect on vascular resistance, Gf.Cr was studied in rat thoracic aorta, which is a 
prototype tissue routinely used for evaluating underlying pharmacodynamic of BP-lowering 
effect [26]. Rat aorta was selected to: a) evaluate effect of the extract on K
+
 and PE-induced 
contractions and thus to distinguish between activity at voltage-operated and receptor-
operated calcium channels, b) distinguish between inhibitory effects of test drug on 
membrane bound Ca
++
 channels and those inside the cells and c) determine if the vasodilator 
effect of Gf.Cr is endothelium-independent or-dependent. Gf.Cr inhibited the PE and high 
K
+
-induced contractions in endothelium-denuded rings at a similar concentration range, 
indicating that it was acting equipotently through blockade of voltage- and receptor-operated 
Ca
++
 channels [27,28]. The results were similar to those obtained with verapamil, a standard 
Ca
++
 antagonist [26]. The CCB activity of the extract was confirmed when it shifted the Ca
++
-
CRCs, constructed in Ca
++
-free medium to the right. Verapamil also caused similar rightward 
of Ca
++
-curves in concentration-dependent manner. Smooth muscle contraction is brought 
about by activation of the 1) membrane bound Ca
++
 channels which are: voltage-dependent 
and receptor-operated Ca
++
 channels [29], but this is not the only mechanism for contractility. 
Ca
++
 influx into the cell can also be guided through 2) Ca
++
 release from internal stores, like 
IP3-sensitive sarcoplasmic reticulum as well [30]. To assess the activity of extract on Ca
++
 
release from intracellular stores, PE control responses were taken in absence and presence of 
Gf.Cr in Ca
++
-free environment. The extract in increasing concentrations suppressed the 
agonist peaks, similar to that caused by verapamil, indicating inhibition of Ca
++
 release from 
internal stores which leads to reduction of intracellular Ca
++
 content. Pre-treatment of tissues 
with plant extract caused rightward non-parallel shift of PE (α-adrenoceptor agonist)-curves 
with suppression of maximum stimulatory effect, characteristic of a Ca
++
 antagonist like 
verapamil. In contrast, phentolamine, a competitive α-adrenergic receptors antagonist [31] 
caused a rightward parallel shift without suppression of maximum response as expected, thus 
ruling out the possibility of adrenoceptor blocking effect of extract. The endothelium-intact 
aorta profile helped in determining that the vasodilator effect of plant extract was 
independent of the endothelium, as was evident from the fact that the vasorelaxant effect of 
Gf.Cr in the endothelium-intact rat aorta was not antagonized by either L-NAME, a standard 
nitric oxide (NO) synthase inhibitor [32], atropine, an antagonist of ACh, that also brings 
about its effect by the release of NO [33] and indomethacin, a cyclooxygenase inhibitor [34], 
an enzyme responsible for the synthesis of prostacyclin (PGI2). The vascular endothelium 
plays a pivotal role in modulating vascular tone through release of mediators like NO and 
PGI2 which diffuses to the cells in the vicinity to cause relaxation [35,36]. The claim that the 
vasodilator effect was endothelium-independent is also strengthened from the aforementioned 
scenario, that when rat aorta was denuded of endothelium and the extract mediated relaxation 
of PE-induced contractions at similar concentration, as in intact preparations. Preliminary 
phytochemical analysis of Gentiana floribunda extract showed the presence of flavonoids, 
saponins, sterols, tannins and terpenes. Flavonoids are reported to possess hypotensive and 
vasodilator action via Ca
++
 antagonism [37,38] and the presence of such compounds in 
Gentiana floribunda may contribute in its observed effects. However the role of other 
constituents cannot be ignored. In acute toxicity testing, the plant extract was found safe up to 
maximum dose (3 g/kg) tested, which is in accordance with its wide therapeutic use. 
Conclusions 
This study showed that Gentiana floribunda exhibits BP-lowering and vasodilatory effects 
mediated through inhibition of Ca
++
 influx via membranous calcium channels and its release 
from the intracellular stores and thus explains its folkloric repute as antihypertensive agent. 
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